Nanosonics Seeks ASX Quotation for New Employee Incentive Shares

Nanosonics Limited ( (AU:NAN) ) just unveiled an update.

Nanosonics Limited has applied for quotation on the ASX of 33,541 new fully paid ordinary shares issued on 30 March 2026. The new securities were issued under the company’s employee incentive scheme and will be quoted, indicating ongoing use of equity-based compensation to attract and retain staff.

The modest size of the issuance suggests limited dilution for existing shareholders while supporting human capital investment in a competitive medtech labour market. The move underscores Nanosonics’ continued reliance on share-based incentives as part of its remuneration framework, aligning employee interests with long-term shareholder value.

The most recent analyst rating on (AU:NAN) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.

More about Nanosonics Limited

Nanosonics Limited is a medical technology company listed on the ASX under the code NAN. The company is known for infection prevention solutions used in healthcare, focusing on automated disinfection systems and related technologies for clinical environments.

Average Trading Volume: 673,371

Technical Sentiment Signal: Sell

Current Market Cap: A$1.14B

For an in-depth examination of NAN stock, go to TipRanks’ Overview page.